The Codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 9, 2013, Pages 5275-5279

  Natukula, Kirmani ^a,b   Jamil, Kaiser ^a   Pingali, Usha Rani ^b   Suresh Attili, Venkata Satya ^c   Naidu Madireddy, Umamaheshwar Rao ^d  

^a Bhagwan Mahavir Hospital and Research Centre   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^c Bibi Cancer Hospital and Research Institute   (India)

^d Central Research Institute of Unani Medicine   (India)

Author keywords

Non small cell lung cancer (NSCLC); X ray repair cross complimenting group I (XRCC1)

Indexed keywords

ARGININE; DNA; DNA BINDING PROTEIN; GLUTAMINE; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; XRCC1 PROTEIN;

ADENOCARCINOMA; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CODON; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INDIA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; ARGININE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CODON; DNA; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMINE; HUMANS; INDIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 84887584400     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.9.5275     Document Type: Article

References (37)

1. Chen S, Tang D, Xue K, et al (2002). DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a chinese population. Carcinogenesis, 23, 1321-5.
2. De Ruyck K, Szaumkessel M, De Rudder I, et al (2007). Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res, 631, 101-10.
3. Divine KK, Gilliland FD, Crowell RE, et al (2001). The XRCC1 399 Glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res, 461, 273-8.
4. Doll R (1998). Uncovering the effects of smoking: historical perspective. Stat Methods Med Res, 7, 87-117.
5. Duell EJ, Millikan RC, Pittman GS, et al (2001). Polymorphism in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev, 10, 217-22.
6. Engin AB, Karahalil B, Karakaya AE, et al (2011). Association between XRCC1 Arg399gln and p53 arg72pro polymorphisms and the risk of gastric and colorectal cancer in Turkish population. Arh Hig Rada Toksikol, 62, 207-14.
7. Fard-Esfahani P, Fard-Esfahani A, Fayaz S, et al (2011). Association of Arg194Trp, Arg280His and Arg399Gln polymorphisms in x-ray repair cross-complementing group 1 gene and risk of differentiated thyroid carcinoma in Iran. Iranian Biomedical J, 15, 73-8.
8. Gangwar R, Manchanda PK, Mittal RD (2009). Implications of XRCC1, XPD and APE1 gene polymorphism in North Indian population: a comparative approach in different ethnic groups worldwide. Genetica, 136, 163-9.
9. Guo S, Li X, Gao M, et al (2013). The Relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in Northeastern Chinese. Plos One, 8, 1-5.
10. Hoeijmakers JH (2001). Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-74.
11. Hu XB, Feng Z, Fan YC, et al (2005). XRCC1 polymorphism and cancer risk: a meta analysis of 38 case-control studies. Cancer Epidemiol Biomarkers prev, 143, 1810-8.
12. Hu XB, Feng Z, Fan YC, et al (2011). Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to glioma. Asian Pac J Cancer Prev, 12, 2981-4.
13. Karkucak M, Yakut T, Evrensel T, et al (2012). XRCC1 gene polymorphisms and risk of lung cancer in Turkish patients. Int J Hum Genet, 12, 113-7.
14. Kiran M, Saxena R, Kaur J (2010). Distribution of XRCC1 genotypes in north Indian population. Indian J Med Res, 131, 71-5.
15. Kirmani N, Jamil K, Naidu MUR (2010). Occupational and environmental carcinogens in epidemiology of lung cancer in South Indian population. Biol Med, 2, 1-11.
16. Knight RD, Parshad R, Price FM, et al (1993). X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members. Int J Cancer, 54, 589-93.
17. Kumar A, Pant MC, Singh HS, et al (2012). Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population. Mut Res, 729, 24-34.
18. Mao Y, Xu X, Lin Y et al (2013). Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk. World J Surg Oncol, 11, 58.
19. Miller SL, Dykes DD, Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nuc Acid Res, 16, 12-5.
20. Misra RR, Ratnasinghe D, Tangrea JA, et al (2003). Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett, 191, 171-8.
21. Mohrenweiser HW, Jones IM (1998). Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat Res, 400, 15-24.
22. Nissar S, Lone TA, Banday MZ, et al (2013). Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: a case control study. Oncology Letters, 5, 959-63.
23. Pachouri SS, Sobti RC, Kaur P, et al (2007). Constrasting impact of DNA repair gene XRCC1 polymorphism Arg399Gln and Arg 194 Trp on the risk of lung cancer in the north-Indian population. DNA Cell Biol, 26, 186-91.
24. Park JY, Lee SY, Jeon HS, et al (2002). Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev, 11, 23-7.
25. Ratnasinghe D, Yao SX, Tangrea JA, et al (2001). Polymorphism of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev, 10, 119-23.
26. Ryk C, Kumar R, Thirumaran RK, et al (2006). Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never-and ever-smokers. Lung Cancer, 54, 285-92.
27. Sabitha K, Vishnuvardhan MR, Kaiser J (2009). Mutation in XRCC1 gene alters the genetic risks of Head and Neck cancer patients. Int J Cancer Research, 5, 58-68.
28. Schneider J, Classen V, Bernges U, et al (2005). XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking. Int J Mol Med, 16, 709-16.
29. Schneider J, Classen V, Helmig S (2008). XRCC1 polymorphism and lung cancer risk. Expert Rev Mol Diagn, 8, 761-80.
30. Shen MR, Jones IM, Mohrenweiser H (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res, 58, 604-8.
31. Spitz MR, Mc Pherson RS, Jiang HH, et al (1997). Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomark Prev, 6, 687-9.
32. Sreeja L, Syamala VS, Syamala V, et al (2008). Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol, 134, 645-52.
33. Thompson LH, Bachinski LL, Stallings RL, et al (1989). Complementation of repair gene mutations on the hemizygous chromosome 9 in CHO: a third repair gene on human chromosome 19. Genomics, 5, 670-9.
34. Wei Q, Cheng L, Hong WK, et al (1996). Reduced DNA repair capacity in lung cancer patients. Cancer Res, 56, 4103-7.
35. Yin J, Vogel U, Ma Y, et al (2007). The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in northeastern Chainese population. Lung Cancer, 56, 153-60.
36. Yu Z, Chen J, Ford BN, et al (1999). Human DNA repair systems: an overview. Environ Mol Mutagen, 33, 3-20.
37. Zhang X, Miao X, Liang G, et al (2005). Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res, 6, 722-6.